Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitamin B 6 | 1 | 2022 | 237 | 0.750 |
Why?
|
CD8-Positive T-Lymphocytes | 8 | 2023 | 4479 | 0.650 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2017 | 46 | 0.590 |
Why?
|
Mitochondria | 2 | 2018 | 3520 | 0.490 |
Why?
|
Aneurysm | 1 | 2017 | 339 | 0.490 |
Why?
|
Paraparesis, Spastic | 1 | 2013 | 8 | 0.480 |
Why?
|
Neurofibromatosis 1 | 1 | 2017 | 569 | 0.430 |
Why?
|
Movement Disorders | 1 | 2015 | 445 | 0.410 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2017 | 518 | 0.400 |
Why?
|
Acyclovir | 1 | 2012 | 272 | 0.390 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2013 | 560 | 0.370 |
Why?
|
Mitochondrial Diseases | 3 | 2017 | 320 | 0.320 |
Why?
|
Herpes Simplex | 1 | 2012 | 470 | 0.320 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 1061 | 0.320 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 627 | 0.300 |
Why?
|
Immunologic Factors | 1 | 2017 | 1580 | 0.300 |
Why?
|
Central Nervous System Diseases | 1 | 2012 | 518 | 0.300 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2023 | 1821 | 0.280 |
Why?
|
DNA, Mitochondrial | 3 | 2021 | 817 | 0.260 |
Why?
|
Multiple Sclerosis | 2 | 2017 | 3079 | 0.260 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1622 | 0.250 |
Why?
|
Endovascular Procedures | 1 | 2017 | 1979 | 0.240 |
Why?
|
Biochemical Phenomena | 1 | 2023 | 59 | 0.230 |
Why?
|
Aminooxyacetic Acid | 1 | 2022 | 7 | 0.210 |
Why?
|
Pyridoxal Phosphate | 1 | 2022 | 127 | 0.210 |
Why?
|
Inflammation | 2 | 2021 | 10638 | 0.200 |
Why?
|
Peroneal Neuropathies | 1 | 2021 | 20 | 0.200 |
Why?
|
Mutation | 6 | 2021 | 29786 | 0.190 |
Why?
|
Cell Differentiation | 1 | 2018 | 11483 | 0.190 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2022 | 337 | 0.180 |
Why?
|
Child Development | 1 | 2012 | 2223 | 0.180 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2012 | 2026 | 0.180 |
Why?
|
Antiviral Agents | 1 | 2012 | 2987 | 0.170 |
Why?
|
Neoplasms | 3 | 2023 | 21683 | 0.170 |
Why?
|
Oxygen | 2 | 2023 | 4189 | 0.170 |
Why?
|
Resistance Training | 1 | 2021 | 165 | 0.170 |
Why?
|
Lactic Acid | 1 | 2023 | 1133 | 0.150 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 362 | 0.150 |
Why?
|
Mixed Function Oxygenases | 1 | 2018 | 272 | 0.140 |
Why?
|
Glutarates | 3 | 2023 | 236 | 0.140 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 134 | 0.130 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2021 | 685 | 0.130 |
Why?
|
Immunotherapy, Adoptive | 2 | 2021 | 1270 | 0.130 |
Why?
|
Spinocerebellar Degenerations | 1 | 2014 | 43 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.130 |
Why?
|
England | 1 | 2015 | 522 | 0.120 |
Why?
|
Nitric Oxide | 1 | 2023 | 2132 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.120 |
Why?
|
Fatigue | 1 | 2021 | 1531 | 0.110 |
Why?
|
Markov Chains | 1 | 2017 | 969 | 0.110 |
Why?
|
Receptors, Dopamine D3 | 1 | 2014 | 110 | 0.110 |
Why?
|
Nerve Degeneration | 1 | 2017 | 748 | 0.110 |
Why?
|
Mice | 9 | 2023 | 81183 | 0.110 |
Why?
|
Oxazines | 1 | 2014 | 298 | 0.100 |
Why?
|
Horner Syndrome | 1 | 2012 | 37 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1889 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2540 | 0.100 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 1312 | 0.100 |
Why?
|
Animals | 11 | 2023 | 168757 | 0.100 |
Why?
|
Demyelinating Diseases | 1 | 2013 | 354 | 0.090 |
Why?
|
Neck Pain | 1 | 2012 | 180 | 0.090 |
Why?
|
Disability Evaluation | 1 | 2017 | 1827 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2022 | 21827 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3638 | 0.080 |
Why?
|
Androgens | 1 | 2015 | 1281 | 0.080 |
Why?
|
Homeostasis | 1 | 2018 | 3340 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1956 | 0.070 |
Why?
|
Humans | 21 | 2023 | 744343 | 0.070 |
Why?
|
Pedigree | 1 | 2013 | 4644 | 0.070 |
Why?
|
Neurology | 1 | 2013 | 763 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2015 | 2585 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.060 |
Why?
|
Sodium Lactate | 1 | 2023 | 3 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5510 | 0.060 |
Why?
|
Alcoholism | 1 | 2014 | 1906 | 0.060 |
Why?
|
Male | 11 | 2021 | 350118 | 0.060 |
Why?
|
Female | 10 | 2021 | 380194 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2023 | 534 | 0.050 |
Why?
|
Education, Medical | 1 | 2013 | 1721 | 0.050 |
Why?
|
Sural Nerve | 1 | 2021 | 106 | 0.050 |
Why?
|
Apoptosis | 1 | 2017 | 9727 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2017 | 63114 | 0.050 |
Why?
|
Adoptive Transfer | 1 | 2023 | 844 | 0.050 |
Why?
|
Middle Aged | 8 | 2021 | 213383 | 0.050 |
Why?
|
Adult | 7 | 2021 | 214055 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13284 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 56430 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15226 | 0.040 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2018 | 86 | 0.040 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2023 | 871 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2014 | 5708 | 0.040 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.040 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 290 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2018 | 675 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2971 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 16718 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16689 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6364 | 0.030 |
Why?
|
Glycolysis | 1 | 2018 | 827 | 0.030 |
Why?
|
Azabicyclo Compounds | 1 | 2014 | 68 | 0.030 |
Why?
|
Cartoons as Topic | 1 | 2013 | 17 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20822 | 0.030 |
Why?
|
Dopamine Antagonists | 1 | 2014 | 296 | 0.030 |
Why?
|
Oxazoles | 1 | 2014 | 189 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3479 | 0.030 |
Why?
|
Adolescent | 2 | 2017 | 85781 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2023 | 5524 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1869 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2014 | 930 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3200 | 0.020 |
Why?
|
Phobic Disorders | 1 | 2013 | 439 | 0.020 |
Why?
|
Brain | 1 | 2017 | 26385 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3586 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3271 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14557 | 0.020 |
Why?
|
Age Factors | 2 | 2015 | 18370 | 0.020 |
Why?
|
Signal Transduction | 2 | 2023 | 23403 | 0.020 |
Why?
|
Skin | 1 | 2021 | 4364 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13102 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1620 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2219 | 0.020 |
Why?
|
Exercise | 1 | 2021 | 5615 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7722 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2014 | 6038 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3521 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9386 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12208 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12072 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9583 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6234 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21746 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18029 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 8987 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25043 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 77449 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 41006 | 0.010 |
Why?
|
Child | 1 | 2014 | 77709 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_